Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
| Company Name | Founded | Funding Stage | Amount | City |
|---|---|---|---|---|
| Aspen Neuroscience | 2025 | Series C | $115.0M | San Diego |
| Invivyd | 2025 | Post-IPO Equity | Undisclosed | Waltham |
| Augmedix | 2023 | Post-IPO Equity | Undisclosed | San Francisco |
| TELA Bio | 2025 | Post-IPO Debt | Undisclosed | Malvern |
| TigerConnect | 2022 | Private Equity | Undisclosed | Santa Monica |
| Iambic | 2025 | Venture - Series Unknown | $100.0M | San Diego |
| Adicet Bio | 2025 | Post-IPO Equity | Undisclosed | Redwood City |
| Forward Therapeutics | 2023 | Series A | Undisclosed | Palm Beach Gardens |
| Repare Therapeutics | 2021 | Post-IPO Equity | Undisclosed | Saint Laurent |
| Tricida | 2022 | Post-IPO Debt | Undisclosed | Menlo Park |
| # | Company | Stage | Amount | Location |
|---|---|---|---|---|
| 76 | Aspen Neuroscience | Series C | $115.0M | San Diego, United States |
| 77 | Invivyd | Post-IPO Equity | Undisclosed | Waltham, United States |
| 78 | Augmedix | Post-IPO Equity | Undisclosed | San Francisco, United States |
| 79 | TELA Bio | Post-IPO Debt | Undisclosed | Malvern, United States |
| 80 | TigerConnect | Private Equity | Undisclosed | Santa Monica, United States |
| 81 | Iambic | Venture - Series Unknown | $100.0M | San Diego, United States |
| 82 | Adicet Bio | Post-IPO Equity | Undisclosed | Redwood City, United States |
| 83 | Forward Therapeutics | Series A | Undisclosed | Palm Beach Gardens, United States |
| 84 | Repare Therapeutics | Post-IPO Equity | Undisclosed | Saint Laurent, Canada |
| 85 | Tricida | Post-IPO Debt | Undisclosed | Menlo Park, United States |
Aspen Neuroscience is a biotechnology company that specializes in personalized cell therapies and autologous regenerative medicine.
Invivyd develops antibodies to transcend the limitations of the human immune system and fight against viral infections.
Medical documentation, Point-of-care notifications, Structured data, Open ecosystem
TELA Bio is a life science company that specializes in soft tissue reconstruction.
TigerConnect is a healthcare collaboration platform that streamlines clinical workflows and systems.
Iambic is disrupting the therapeutics landscape with its unique AI-driven drug-discovery platform.
Adicet Bio is a biotechnology company discovering and developing first-in-class allogeneic gamma delta CAR t cell therapies for cancer
Forward Therapeutics is a biopharma comapny targeting treatment of chronic inflammatory disorders.
Repare Therapeutics is a developer of oncology drugs designed to target specific vulnerabilities of tumor cells.
Tricida operates in the healthcare industry focusing on pharmaceutical business.
Stairway Medical is a developer of implantable brain-computer interface technology.
QL Biopharma focuses on developing innovative drugs and premium me-too drugs targeting metabolic diseases.
Mendra uses AI to accelerate clinical development and commercialization of breakthrough medicines for diseases with high unmet need.
Corvus Pharmaceuticals is a clinical-stage biopharmaceutical company.
Started in 2013, Redcliffe Hygiene Private Limited is India's fastest growing hygiene company.
AirNexis Therapeutics develops clinical-stage therapies for chronic obstructive pulmonary disease and other pulmonary conditions.
Biobeat is a med-tech company that develops remote patient monitoring and data collection tool.
BIOMx is a microbiome therapeutics company developing synbio phage therapies to eradicate harmful bacteria in chronic diseases.
Yarrow is developing a first-in-class antibody targeting TSHR for the treatment of Graves’ disease and thyroid eye disease.
BlossomHill Therapeutics is a biopharmaceutical company focusing on oncology and autoimmune disorders.
Proviva Therapeutics is a pro-drug design platform for cytokines and other fusion proteins.
Verastem is a biopharmaceutical company developing new medicines to improve the lives of patients with RAS/MAPK pathway-driven cancers.
TandemAI is an advanced technology company dedicated to reinventing drug discovery infrastructure.
NextCure is a biopharmaceutical company focused on discovering and developing next generation immuno-oncology-based drugs.
Braveheart Bio is a clinical-stage biotechnology company focused on developing precision therapies in the cardiovascular disease space.
OrbiMed has invested in 239 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
OrbiMed's top investment sectors include Biotechnology, Health Care, Medical, Therapeutics, Pharmaceutical. The firm invests across 30 different industry categories.
Among tracked funding rounds, Corvus Pharmaceuticals received $201.0M in a Post Ipo Equity round. OrbiMed's total known invested capital is $12.2B.
OrbiMed's average investment size is $87.5M across its portfolio of 239 companies.
Recent OrbiMed portfolio additions include Aspen Neuroscience, Invivyd, Augmedix, TELA Bio, TigerConnect. These companies were founded in 2020 or later.
Discover portfolio companies of other leading venture capital firms and investors.
View All Investors